Effects of Pioglitazone on Visceral Fat Metabolic Activity
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms PIO-FAT
- 05 Apr 2013 New trial record
- 27 Mar 2013 Biomarkers information updated